The user wants me to evaluate the earnings call transcript against two gates and return only YES or NO. Let me analyze Gate 1 first: Is there a positive, current development that analysts probe in Q&A, where management's answers add more concrete operating detail than the prepared remarks? The main positive developments on this call: 1. European approval of Vafseo (vadadustat) - approved in 32 countries 2. FOCUS trial positive results - three times weekly dosing 3. FDRR process with FDA - awaiting response 4. Auryxia revenue Let me look at the Q&A to see if analysts probe any of these and if management adds new detail. Q1 from Allison Bratzel: About the FDRR process - John Butler says they've been in regular contact, had a formal type A meeting, expect an answer within 30 days. This is mostly restating what was in the prepared remarks. No new concrete detail. Q2 from Allison: About EU partnership - John Butler says it's an active process, typical transaction, dialysis is complicated, finding a partner who understands the market. This is fairly generic - no new specifics about who the partners are, what terms, etc. Q3 from Allison: About FOCUS trial data - John Butler explains the importance of three times weekly dosing for hemodialysis, mentions a manuscript being worked on, expects data at ASN meeting. This adds a small detail (manuscript, ASN meeting) but is mostly explanation of why the dosing matters. Q4 from Thomas Yip: About FDRR scenarios - John Butler describes best/worst case scenarios. This is somewhat new detail about the possible outcomes but it's about the process, not about a development going well. Q5 from Thomas Yip: About Auryxia beyond loss of exclusivity - John Butler explains the TDAPA period, CMS bundling, how dialysis providers would be incentivized to use branded products. This is about future prospects, not current operations. So looking at the Q&A, the analysts ask about: 1. FDRR process - management mostly restates, no new concrete detail 2. EU partnership - generic response, no specifics 3. FOCUS data - small new detail (manuscript, ASN) 4. FDRR scenarios - process explanation 5. Auryxia future - future prospects, not current The positive developments (European approval, FOCUS results) are mentioned in prepared remarks. In Q&A, management doesn't really add substantial new operating detail about these developments.
Akebia Therapeutics, Inc.
The call grade, management's tone measured against 177,437 other calls, what changed since the quarter before, and every one of the 500 checks.
This is the current report. Unlock its call read, expected move size, and all 500 answers.
- Is there a questioner from an investment bank other than the first three analysts who ask questions?
- Does the operator use the phrase "next question" at least three times?
- Does any speaker use "we're" where "we are" could substitute, more than twenty times overall?
- Does the transcript contain the phrase "next question" at least twice?
30 markers, measured against 177,437 calls
Language counted straight from the transcript, behaviour read by the 500 checks, tone above. The band is the middle half of every call we have graded; a flag means this call sits outside it.
All 500 AI checks
Q4 2025 · 500 checks
Every answer is below. Open any check to see what its YES or NO means.
YES Does an executive answer a question by describing a process rather than an outcome?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a question the executive answers with a question back to the analyst?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone compare the company to an unnamed "competitor" or "peer" rather than naming it?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use "historically" or "traditionally" while defending a current practice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is a departure, transition, or role change mentioned only in passing without a thank-you or tribute?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference a private conversation ("as I told...", "as we discussed offline")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the transcript contain the phrase "next question" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a question spanning more than five sentences?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question containing multiple sub-questions (three or more)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO answer a question personally after another executive initially responds?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "if you look at" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst preface a question by summarizing the company's stated results?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "obviously" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "guidance" in the same sentence as a specific number?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst say "congrats" or "congratulations" to management?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "scale" or "scaling" used as a verb?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question beginning with a number ("two questions", "three quick ones")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst say "thank you" before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst name two or more executives when asking their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "outperform," "outperformance," or "beat" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "the environment" when describing market conditions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "momentum" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive begin an answer with "Great question," "Thanks," or "Appreciate"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "adjusted" or "non-GAAP" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "thank you" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "with that" as a transition phrase?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "on a comparable basis" or "adjusted for"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "moving to" or "turning to" when changing topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "over to you" or "I'll turn it over"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "operator" aloud during the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone repeat the same stock phrase three or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "as you know" to introduce a claim?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker apologize without attaching a fix to the apology?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the call end without any closing statement from the CEO?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a request to move the call along or to the last question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive answer a question with another question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive mention the weather?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a negotiation currently in progress?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive describe a competitor with anything resembling respect?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator announce more than ten questioners in the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "kind of" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any question include the word "color"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO deliver the opening remarks rather than the CFO or IR head?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "if I may" or "if you don't mind"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive's first sentence include the word "revenue"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst use the word "clarification" or "clarify" in a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question contain the phrase "color on" or "some color"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator use the phrase "our final question" before closing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "let me" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "aggressive" or "aggressively" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question referencing "the puts and takes"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "to be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include a compliment followed by "but"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the word "sequential" or "sequentially" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "with that" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "for the benefit of" or "just to remind" when restating context?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "early days"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "journey" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the speaker describe a strategy as "disciplined" without describing any trade-off?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is there an apology offered to a specific analyst by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "to be honest" or "frankly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone promise to "follow up" or "take that offline" and fail to commit to when?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone on the call interrupt a colleague mid-sentence?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does someone use a personal anecdote rather than a metric to justify confidence?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "question" appear in the operator's speech more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "growth" appear at least ten times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "a couple of"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask about capital allocation or buybacks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "strong" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive use the phrase "we're seeing" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "opportunity" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management use the word "confident" or "confidence" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "record" appear at least twice in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "team" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management promise to follow up or take a question offline?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "we're excited about" or "we're pleased with"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Do two or more analysts from the same firm ask questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "moving forward" or "go forward"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management mention a specific number of stores, locations, or markets?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the word "folks"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive use the phrase "we believe"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the operator use the phrase "next question" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst mention a specific percentage figure in their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "quarter" appear in at least ten questions or answers during the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does at least one analyst ask a question about margins or costs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO answer the majority of analyst questions personally?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a question phrased as "Can you talk about" or "Can you speak to"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO speak during the Q&A portion at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any question reference a specific quarter (e.g., "fourth quarter") by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator interrupt the Q&A to announce time is limited or that this will be the last question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question beginning with "just" (e.g., "just curious")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask about a specific dollar amount or number stated in the prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question begin with the words "can you" or "could you"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the phrase "if you look at" during the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO answer at least one question without the CEO speaking first?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a question containing an explicit comparison to a competitor company?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "moving on" or "next question" come from the operator?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask about capital allocation (capex, buybacks, M&A, or dividends) in one question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "color" appear (e.g., "add some color") in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear at least five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question contain the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "I think" at least three times within a single answer?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive begin an answer by restating the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive's answer exceed 300 words in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO answer the first analyst question personally?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "obviously" appear in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain the word "margin" more than ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive begin an answer with "So" as the first word?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "if I may" or "if I could" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive say "let me" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question contain the word "specifically"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "momentum" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management mention "margin" or "margins" in prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "definitely" used by any speaker?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "seasonality" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "robust" to describe demand, growth, or the pipeline?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the word "leverage" as a verb at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive use the word "team" when referring to employees?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive say "that said" or "having said that" to introduce a caveat?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst's question include the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "great question" at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we remain confident" or "we are confident"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive say "thank you" immediately after finishing an answer?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive cite a specific dollar figure greater than one billion?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst's question contain the word "curious"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst reference a specific prior quarter by name (e.g., "last quarter")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "obviously" two or more times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a follow-up in the same turn after their first answer?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask about a specific geographic region or market?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a question that includes the phrase "long term" or "long-term"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "margin" or "margins" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "opportunity" or "opportunities" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "we'll come back to that" or defer an answer to a follow-up?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" three or more times in the Q&A section?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "free cash flow" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "momentum"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO mention at least one specific customer segment by name (e.g., "enterprise")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "take your question" or "take the question" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst introduce themselves by name before asking their first question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "including" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management reference "the macro environment" or "macroeconomic" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive reference "our team" or "the team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator announce more than one analyst from the same firm?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any prepared remark mention "headwinds" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "with that, I'll turn it over"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the phrase "capital allocation"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive decline to answer, citing that something will come later or is not disclosed?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a two-part question containing the word "but"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone ask a follow-up question in the same turn after their first question is answered?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone answer "yes" or "no" as the first word of a response?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" at least ten times in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive use the phrase "if you look at" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst begin their question with "Hi" or "Hello" as a greeting?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we are excited about" without naming a number?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst reference a peer company's results or valuation?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "just to clarify" or "just to be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "headwind" or "headwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "tailwind" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the word "momentum"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "investments" appear in the context of margins or costs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention "FX" or "foreign exchange"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "efficiency" or "productivity" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank the executives or congratulate them before asking a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "great question" or "thanks for the question"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "as we said last quarter" or reference a prior call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "going forward" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "levers" when discussing actions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts by name at any point after a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "we'll take that offline" or offer to follow up after the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "committed" regarding a target?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO's prepared remarks mention "macro" or "macroeconomic"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "the vast majority"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "temporary" or "transitory" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is an analyst's question answered with "great question" or similar?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a questioner from an investment bank other than the first three analysts who ask questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question that includes a reference to a specific dollar figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" at least ten times across the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "thank you for taking my question" or "thanks for taking my question" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's first sentence contain a compliment or thanks before asking their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO present in both the prepared remarks and the Q&A portion of the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally deliver the closing remarks of the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO's prepared remarks contain the word "team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the phrase "moving on" or "with that" to transition between topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "in terms of" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO First-person singular ("I believe," "I think") used more by the CFO than the CEO.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES A single question receives answers from two different executives.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES A hedge word ("maybe," "sort of") appears inside a direct quantitative claim.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the word "obviously"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear in both prepared remarks and the Q&A section?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive defer a question to another executive by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Someone uses the word "honestly," "frankly," or "to be clear."
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "ecosystem" or "platform" without a number attached?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the transcript contain the word "certainly" three or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone begin an answer by restating or paraphrasing the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst reference a competitor by name during their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does a speaker say "let me" at least twice in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO The transcript contains an apology unrelated to financial results.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO The word "challenge" is spoken more often than "opportunity."
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "seasonality" or "seasonal" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO The phrase "as you know" appears at least twice.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the word "challenge" or "challenges" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone mention "weather" as a factor affecting results?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "thank you" to the analyst before answering a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "great question" or similar praise of a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO The final question is answered noticeably shorter than the opening ones.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we remain" followed by a verb (e.g., "we remain committed")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive cite a conversation with a customer that has no verifiable specificity (unnamed, undated, unquantified)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain a sentence that begins with "What I would say is"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question mention a specific percentage or dollar figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally answer more questions than any other executive?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator say "our final question" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "opportunity" or "opportunities" appear at least five times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "clearly" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "leverage" appear as a verb at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's first name get used by an executive when thanking them?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator announce more than five questioners?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Are there more than ten analyst questions in total?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator use the phrase "our next question comes from" more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Are the CEO's prepared remarks longer than the CFO's, judged by speaker turns on the transcript page?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management say "we are not going to comment on" or equivalent refusal language?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Executive corrects an analyst's premise.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO's prepared section exceed the CEO's in number of paragraphs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally answer more than half of the analyst questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst mention the word "margin" in their first question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Executive uses the word "excited" more than twice.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a multi-part question containing three or more distinct questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a two-part question signaled by "and also" or "and secondly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst begin with a compliment, such as "great quarter" or "congrats"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "we said" when recalling prior statements?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst begin their turn with "thanks" or "thank you"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "headwind" or "tailwind" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "synergies" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst address a question to two or more executives by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "capital" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "we feel" rather than "we believe" or "we think"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "capital" appear in at least three different speakers' turns?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive use the phrase "over time" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "as I mentioned" or "as we said" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO open the call before any analyst questions by mentioning the macro environment?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "we are pleased" or "we're excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the word "leverage" (financial or metaphorical)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst thank management before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "automation" or "productivity" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "uncertainty" or "uncertainties" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "year over year" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "leverage" or "leveraging" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Currency headwinds mentioned unprompted.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the phrase "a number of" used at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "best-in-class" or "industry-leading"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "momentum" appear at least twice in prepared remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the phrase "on a constant currency basis" or similar currency adjustment used?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include the phrase "just to clarify"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "the team" appear at least twice in management remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "so clearly" or "quite frankly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the phrase "we believe" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Speaker says "we don't guide" on anything.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the word "quarter" at least ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" or "macroeconomic" appear at least twice in the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "typically" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive state they will "come back to" a question or follow up later?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts for their questions at any point during Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Speaker admits being surprised by anything.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the phrase "going forward"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the phrase "going forward" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "stability" or "stable" when describing demand?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Word "normal" used about demand.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "stay tuned" or "more to come"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management describe a cost program, restructuring, or efficiency initiative by a proper name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO's prepared section mention interest expense by name or figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "volatility" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Executive mentions a hobby or personal anecdote.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "pipeline" appear without a dollar figure attached?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "the macro" or "macro environment" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "our team" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "great question" or "good question" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "we remain" followed by an adjective?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts by name when responding?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "flexibility" or "flexible" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "takeaway," "take out," or "take rate"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Analyst compliments the team before asking a question.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use "we're" where "we are" could substitute, more than twenty times overall?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst reference the CEO or CFO by first name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "obviously" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the word "pipeline" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "moving on" or "let me turn it over" during prepared remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask a question starting with "just"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "headwind" or "headwinds" more than once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst use the phrase "to clarify"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the phrase "year over year" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive cite a conversation with a customer, partner, or employee as evidence?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any question go to a named executive other than the CEO or CFO?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "to be clear" or "let me be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone mention a competitor by name without being prompted?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a question that management declines to answer directly, citing timing or disclosure constraints?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question explicitly reference the company's prior guidance or outlook?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "next question" or does the operator use the word "final" before the last question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "invest" or "investment" appear at least five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO handle a strategic question instead of a financial one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst flatter management within their first sentence of speaking?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask two questions when told to ask only one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "underlying" to modify a business metric?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "excited" or "pleased" at least twice in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear in the prepared remarks (not just Q&A)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "margin" used with a number attached (e.g., "400 basis points")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "record" preceding a noun (e.g., "record margin")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive answer a question by citing a competitor's actions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "macro" or "macroeconomic" appear in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "challenges" appear more than once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO begin an answer with "look" or "listen"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "inflation" appear anywhere in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a pause or silence acknowledged on the call ("I think we lost you")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive name a specific competitor during the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "challenges" appear at least three times in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "we don't break that out" in response to a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a metric as "noisy" or "lumpy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive mention a specific number of percentage points when discussing market share?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does a speaker correct a figure they themselves just stated?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO refer to a competitor by name rather than "competition" or "peers"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO mention their own tenure or years of experience unprompted?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "the team" when taking ownership would be natural?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone blame weather, holidays, or calendar quirks unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone cite a personal anecdote involving a customer conversation?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "a little bit"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the CFO the speaker for at least one analyst question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "guidance" appear in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "we're excited" or "we are excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "dividend" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "invest" or "investment" used more than twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "invest" or "investment" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone cite a percentage of revenue from a specific segment?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "challenge" or "challenging" appear at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone describe cutting discretionary spending like travel or hiring?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "year over year" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "liquidity" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript mention refinancing, maturity dates, or debt coming due?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention selling assets, real estate, or equipment to raise cash?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference "the macro" or "macro environment"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "capacity" mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "our customers" rather than naming a customer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript include a question about interest expense or debt service?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "working capital" appear in a context other than a seasonality excuse?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone reference borrowing from a bank or drawing on a credit facility?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "cost" appear in the first ten sentences of prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "we remain confident" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention covenants, amendments to loan documents, or lender conversations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "with that" or "that said" to pivot?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive open their first answer by thanking the analyst?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst's question include the word "capex" or "cash flow"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "headline" or "headwinds" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "core" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst's turn contain the word "congratulations"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question containing "how" and also "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "as we mentioned" or "as I mentioned" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Are there more than eight analyst questioners?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's question include a percentage figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's question contain the word "guidance"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO's prepared remarks exceed 1,000 words?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "if you look at"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally answer the first question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "tailwind" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "balance sheet" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO make closing remarks after the Q&A ends?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "structurally" or "secular"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator say "our next question" two or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the final questioner get an explicit closing acknowledgment from the operator ("last question" or similar)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "business as usual" or "as expected" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst preface a question with "quick" or "quickly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive state a specific numeric percentage when answering a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "in terms of" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a question that clearly annoyed the executive, visible in the reply's abruptness?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "guidance" appear in the Q&A section?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "strong" appear more than five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "thank you" appear more than ten times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a question containing the word "margin"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "guidance" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "thank you" appear at least ten times anywhere in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive begin an answer by restating the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask about capital allocation or share repurchases?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "challenge" or "challenging" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "opportunity" or "opportunities" appear more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a villain—market conditions, regulation, currency—that behaves consistently across the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenging" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "certainly" appear at least once in management's answers?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a personal, warm, or congratulatory question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "capital" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question the prepared remarks already answered?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "quarter" appear at least twenty times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any single analyst ask more than two questions during the whole call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "on a year-over-year basis" or "year over year" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "headwinds" or "tailwinds" used?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "margin" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "confidence" or "confident" spoken by any executive?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "call it" or "let's call it" before an estimate?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "going forward" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "coming back" or "circling back" to take a follow-up?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "inflation" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "we believe" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management use the phrase "going forward"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the word "robust"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the phrase "if you will" or "so to speak"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "appreciate" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "at the end of the day"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone tell a self-contained anecdote with a beginning, middle, and end?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive use the phrase "our team"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain a silence, pause, or "we'll come back to that" that never resolves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone describe a customer, employee, or competitor as a named character with a motive?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive say "we're pleased" or "I'm pleased"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a moment of modesty—someone crediting luck or timing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "excited" or "exciting" used by management at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "just" five or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question begin with "Can you" or "Could you"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "quick" or "quickly" appear in three or more analyst questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst ask for guidance on a metric management did not offer unprompted?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a question about capital allocation (buybacks, M&A, debt, or dividends)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst use the word "clarify" or "clarification"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "obviously" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management refer to a prior call or prior quarter's commentary when answering?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "actually" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive begin an answer with "Look," or "So,"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "challenging" or "challenges" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator run out of queued questions and close early?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst apologize or preface with "sorry" before asking?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "excited" used by the CEO more than the word "confident"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "the right" before a noun ("the right team," "the right decisions")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "guidance" appear more than five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "tailwind" or "headwind" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's question begin with a compliment or congratulation?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst apologize before or during their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Are there more questions about revenue than about costs?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "challenging" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "on a" four or more times total (e.g., "on a constant currency basis")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive answer begin with "Sure" or "Yes" followed by a comma?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "from a ... perspective" (e.g., "from a margin perspective")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "we're not going to" in response to a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management decline to answer by citing a future event ("we'll address that in..." or "at our upcoming...")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "quarter" appear at least 20 times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a mention of "FX," "currency," or "foreign exchange"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "that's right" or "that's correct" to an analyst?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "leverage" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "leverage" used at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "headwinds" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "great question" or thank the analyst before answering?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone attribute results to "the team" rather than to strategy?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "going forward"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst begin their question with "congratulations"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst thank management at the end of their turn?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone describe the future with "We believe" more than "We expect"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does a speaker say "normal" or "normalized" about conditions that predate any disruption mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "momentum" used without a stated metric attached to it?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "solid" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there an analogy to a machine, engine, or flywheel?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "visibility" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "base case" or "scenario" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we take that seriously" or "we're very focused on"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "to your point" or "as you mentioned" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator say "thank you" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management mention a specific competitor by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management say "the team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "fundamentally" appear at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "ahead of" precede any mention of guidance or expectations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any single speaker say "right?" as a tag question at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the phrase "on a consistent basis" or "consistently"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does a speaker begin a sentence with "To be honest" or "To be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "strategic" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker describe a business unit as "healthy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "fundamentals"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "resilient" or "resilience" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator mention a queue or "next question" more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a follow-up after their initial answer ("follow-up", "second one", "just one more")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question containing the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "if you look at" before citing a number?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "last question" or "final question" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "clearly" appear anywhere in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO speak first among named executives in the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "headwind" or "headwinds" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CFO mention a specific percentage greater than ten?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "going forward" appear at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "team" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "confident" appear in any executive's remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst thank management at the start or end of their turn?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO use the word "incredibly" at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "team" to refer to company personnel?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "to your point" when answering a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "with that" to transition between speakers or topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "transformation" or "transformational" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "moving on" or "next question" themselves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "hedging" or say "to hedge"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst identify themselves with a two-part introduction (name and firm)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "talent" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "capacity" used more often about factories than about people?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive confess to having too much of something physical somewhere?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is a supplier or vendor mentioned by name at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive blame weather, season, or geography for a shipment or delivery issue?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
Archived AI reasoning
Earlier Artul research experiments on AKBA calls. Open a question to read the model's original reasoning.
NO Answers go deeper than the script: questioning keeps surfacing new concrete detail behind a positive development — compa
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer only YES or NO. Need evaluate both gates. We need analyze transcript. Need determine Gate1: positive current development with Q&A adding more concrete operating detail than prepared remarks. Gate2: engine is company's own actions vs external. Let's parse. Company Akebia, vadadustat under FDA review, PDUFA March. Launch prep. Auryxia revenue growth. Q&A topics: ASN feedback, competitor daprodustat data, Vifor collaboration, sales force, TDAPA, supply, Auryxia, Part D lawsuit, Europe. Positive current development? Maybe "preparing for launch" not current actual business? Auryxia revenue growth? Q&A about Auryxia? Let's see. Prepared remarks: John says developments increase confidence, FDA mid-cycle, Phase3 data, launch prep. Market opportunity. Dell: commercial prep, distribution with Vifor, TDAPA, Auryxia revenue grows. Dave: financials. Q&A: First question about ASN feedback and differentiation. John answers general, mentions Spherix presentation, 60% physicians likely prescribe, daprodustat data confirms. Steve adds. This is not concrete operating detail? It's about market feedback, not company's own development? Maybe. Second question: panel, dapa, Vifor. John answers about panel no indication, daprodustat data, Vifor. Dell adds access to FMC. Not much new. Third: sales force/MSL sizing, Otsuka support. John/Dell answer: existing team, leverage, Otsuka. Some detail but not concrete numbers? Dell says 140 commercial, 110 field, 13 MSLs in later question. That's in Q&A. But is that about a positive current development? Launch prep? It adds specifics about team size. But is that "operating detail" about development? Maybe. Fourth: supply readiness, TDAPA, Auryxia. John says two API and two drug product suppliers, comfortable supply. Dell explains TDAPA process, launch before TDAPA, revenue ramp linked. Auryxia market challenging, team resilience. This is additive? Supply chain detail. Fifth: SG&A, Medicare Part D. Dave says team largely in place. John discusses lawsuit dismissed, legislative efforts. Not positive current. Sixth: sales footprint, training, market size. Dell gives team numbers, readiness activities. John clarifies $2B market, first to market.
The transcript discusses the merger with Keryx, vadadustat clinical trials, and financial results. The main positive current development is the merger with Keryx and the progress of vadadustat trials. However, the Q&A does not produce more concrete operating detail than the prepared remarks. The questions about the FDA type-C meeting, merger integration, and trial timelines are answered with generalities and restatements. The answers do not add substantial new specifics beyond what was in the prepared remarks. The development is also largely dependent on external factors like MACE accrual rates, which are not fully controlled by the company. The merger is a plan, not yet closed. The trial progress is ongoing but the Q&A does not add new concrete details. Therefore, Gate 1 is not satisfied.
NO Quarter of firsts: the period's story is built from first-time events the company has never done before, now starting to
Original model output from the research archive. It may be verbose or include the model's working notes.
The question asks whether management's account of the just-reported period is built substantially around first-time events — real things the company actually did or achieved in or around this period that, in management's own telling, the company had NEVER DONE BEFORE — with management treating these firsts not as curiosities but as the OPENING INSTANCES of activity that is now beginning to repeat or scale. Let me analyze the transcript carefully. Key events in the transcript: 1. Vadadustat is under FDA review with PDUFA date March 29, 2022 (not yet approved) 2. The MAA was submitted to EMA last month (October 2021) - this is a first-time event 3. Vadadustat was launched in Japan by partner MTPC just over a year ago 4. The company is preparing for a potential US launch Let me look for first-time events that management describes as genuine firsts: - The EMA submission: "we have worked closely with our collaboration partner Otsuka, on the European marketing authorization, which was submitted last month to the European Medicines Agency." This is a first-time event - first submission to EMA. - The Japan launch: "The product was launched by our partner MTPC just over a year ago in Japan." This is a first-time event but it happened over a year ago, not in the recent period. - The UT Health study expansion: "UT Health has decided to expand their study beyond the initial 400 patients, an enrollment targets they've now surpassed." This is a first-time event of sorts. - The PDUFA date is approaching but approval hasn't happened yet. Now, are these presented as "beginnings with repetition already forming"? The EMA submission is a first, but it's a submission, not a commercial activity. The company says "We will continue to support Otsuka as the EMA begins the review process." This is a first submission, but the repetition isn't really forming - it's a one-time submission event. The Japan launch happened over a year ago, so it's not in the recent period. The UT Health study expansion - this is a study, not a commercial activity. The company is preparing for a potential US launch, but that's contingent on FDA approval, which hasn't happened yet. The question says "NO if the 'firsts' are still plans, pipeline, pilots without real transactions, or contingent on approvals, financing, or decisions not yet made." The US launch is contingent on FDA approval - not yet approved.
NO Proven engine, fuel already in the tank: a working growth driver plus already-held means to multiply it
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: Does management describe BOTH of the following about the SAME part of the business, as one connected present-tense story? (1) A PROVEN, ALREADY-PRODUCING GROWTH ENGINE THAT IS STILL SMALL RELATIVE TO ITS ROOM. Management identifies a specific driver of growth — a product, service, offering, location type, customer relationship, market, asset, or capability — that is ALREADY generating real business today (actual revenue, orders, customers, volumes, output, or usage in the recent period, described with concrete substance rather than as pipeline, plans, or market opportunity), and management conveys, directly or plainly in substance, that this driver has so far captured only a small part of what it can reach — because it is early in its rollout, present in only a fraction of the customers, sites, applications, or territory available to it, or recently started and still ramping — so that the reported results reflect only the beginning of what this engine is already doing. (2) THE MEANS TO MULTIPLY IT ARE ALREADY IN THE COMPANY'S HANDS. Management describes resources the company ALREADY possesses or has ALREADY secured that it is now using, or beginning to use, to scale that same driver up — in whatever form fits the business: cash or self-generated funds being deployed into it; capacity, facilities, inventory, or supply already built or secured that it can fill; an existing customer base, footprint, network, or channel through which it can be pushed; approvals, qualifications, or positions already held that permit its expansion; a repeatable formula, site type, or playbook already demonstrated that is now being replicated; or people and capability already in place being pointed at it. The multiplication must be presented as already underway or already resourced from what the company has — not dependent on raising outside money, winning approvals not yet obtained, or demand that has not yet appeared. We need to find if management describes such a growth engine. The transcript is about Akebia Therapeutics, which has Auryxia (a product) and vadadustat (not yet approved). The question is about a proven, already-producing growth engine that is still small relative to its room. Auryxia is a commercial product generating revenue. But is it described as still small relative to its room? Let's see.
NO Trajectory bent upward recently, and management says the change has only started showing
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Need determine if management conveys recent real bend upward and still early. Need only transcript. We need parse. Company Akebia, vadadustat PDUFA upcoming, not approved yet. Auryxia revenue growing. They discuss launch prep. Is there a recent bend? They mention "Developments over past quarter continue to increase confidence" including FDA mid-cycle review, ASN data. "We are excited about vadadustat's potential to be first-in-class HIF-PHIs in US. This is a much larger market opportunity than we anticipated just a few months ago." That is about potential, not actual business performance. They have not launched vadadustat. Revenue: total revenue $40.8M vs $60M prior year due lower collaboration revenue. Auryxia net product revenue increased 7% to $36.8M vs $34.4M. They say "Revenue for Auryxia continues to grow. We are encouraged... continue to expect Auryxia to deliver annual revenue growth for 2021." Is that a recent bend? It's continuing growth, not necessarily after flat/declining. They mention challenging market, COVID mortality, team adapted. No clear contrast old path vs new direction. They mention "This is a much larger market opportunity than we anticipated just a few months ago" due being first to market instead of second. But that's future potential, not actual results. They say "We have a tremendous opportunity to bring potential first-in-class product to market" not yet approved. No actual recent orders/wins/volumes. The change is not in reported results. They are preparing for launch. The question asks "does management convey that company's trajectory has RECENTLY BENT UPWARD — within last few quarters something real changed in how business is performing, so current direction meaningfully better than path before — AND management indicates change still early?" Need answer NO because no actual bend in business performance; it's about anticipated approval/launch. Also "still early" maybe yes for launch prep, but no actual bend. Need be careful: They say "This is a much larger market opportunity than we anticipated just a few months ago" due being first to market. But that's not "business performing" yet. They also mention "Developments over past quarter continue to increase our confidence" not actual performance. Auryxia growth is continuing, not a bend. So answer NO. Need final only YES or NO.
NO Priced like the old business, running like a new one: management is redirecting the call away from the metric investors
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: does management repeatedly redirect attention away from the measure or storyline by which the company is conventionally judged and toward a different part of the business that it says is already earning today — and does management indicate that this different part is not yet what the company's reported results or outside understanding reflect? We need to analyze the transcript. The company is Akebia Therapeutics, developing vadadustat for anemia due to CKD. They have a product Auryxia (for hyperphosphatemia) that is currently commercial. The call is about Q3 2021 results. The main focus is on vadadustat, which is not yet approved (PDUFA date March 2022). They discuss launch preparations, data, etc. They also discuss Auryxia revenue. The question is about management redirecting attention away from the conventional yardstick (likely the company's overall financials or vadadustat prospects?) and toward a different part of the business that is already earning. But what is the conventional yardstick? Possibly the company is judged on its pipeline (vadadustat) or its overall revenue. Management might be saying that the real value is in Auryxia? But Auryxia is already earning and is part of reported results. Actually, the transcript shows that Auryxia net product revenue increased 7% to $36.8M. The company also has collaboration revenue from Otsuka. The total revenue was $40.8M, down from $60M due to lower collaboration revenue. So the conventional measure might be total revenue or the vadadustat program. But management is not setting aside the conventional yardstick; they are discussing vadadustat extensively as the future. They are not saying that the thing outsiders watch (maybe vadadustat approval) is not the right thing. They are actually emphasizing vadadustat's potential. They are also discussing Auryxia as a foundation. But the question is about redirecting attention to a different part that is already earning and not yet reflected in reported results. Auryxia is already reflected in reported results. So that doesn't fit. Alternatively, maybe the conventional yardstick is the company's overall financial performance, and management is redirecting to the potential of vadadustat? But vadadustat is not yet earning; it's awaiting approval. So that fails the "already earning" condition.
NO Ground-level proof points accumulating: management narrates several small, named, recent wins and treats them as the lea
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer based on the transcript. The question asks: On this call, does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from inside the business, each one identifiable on its own — AND does management explicitly treat these accumulating episodes as the LEADING EDGE of a broader improvement that is still early? We need to check both halves. The call is about Q3 2021 results. Management discusses vadadustat progress, Auryxia revenue, etc. Let's look for specific episodes. The call mentions: - FDA's completion of mid-cycle review and release of additional Phase 3 data at ASN Kidney Week. - Launch of vadadustat by partner MTPC in Japan over a year ago, and HIF-PHI share growing in Japan. - European marketing authorization submitted to EMA last month. - UT Health's investigator-sponsored study of vadadustat for ARDS, expanded beyond 400 patients. - Auryxia revenue growth, but that's aggregate. - Also mention of TDAPA, but that's future. Are these "small, concrete, ground-level wins"? The FDA mid-cycle review is a regulatory milestone, not a ground-level win like a customer signing. The ASN data presentation is a conference presentation. The EMA submission is a regulatory event. The UT Health study expansion is a clinical trial progress. These are not typical "wins" like specific customers or accounts. They are more like regulatory and clinical milestones. The question asks for "several small, concrete, ground-level wins" that are "individually identifiable" and "recent episodes from inside the business" like a particular customer, account, partner, site, product, etc. The examples given are operational-level facts. The call's positive story is mainly about vadadustat's regulatory progress and launch preparation. There is no mention of specific dialysis providers signing contracts, specific sales wins, etc. The Auryxia revenue growth is aggregate, not specific episodes. Also, management does not explicitly connect these episodes into a broader still-early pattern. They talk about preparing for launch, but they don't say "these wins are leading edge of a broader improvement." They mention that they are encouraged by developments, but they don't frame it as accumulating episodes leading to a larger trajectory. Thus, the answer is NO.
NO Running ahead of their own plan — and management has already acted on it
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management indicates that some real, operating part of the business performed ahead of management's own prior expectations, plan, or timeline in the period just reported, and has the company already taken at least one concrete action in response to that favorable surprise. Let's scan the transcript for any such statements. John Butler: "We have a tremendous opportunity to bring a potential first-in-class product to market... An approval has the potential to be a pivotal catalyst... Developments over the past quarter continue to increase our confidence and a path for approval and launch success for vadadustat, including the FDA's completion of our mid cycle review and release of additional global Phase 3 data for vadadustat during ASN Kidney Week... Our team has also made significant progress preparing for successful launch... We are excited about vadadustat's potential to be the first-in-class HIF-PHIs in the US. This is a much larger market opportunity than we anticipated just a few months ago." That phrase: "This is a much larger market opportunity than we anticipated just a few months ago." That is a favorable surprise relative to management's own prior expectation. But is it about real operating activity? It's about market opportunity, not necessarily current operating performance. However, the context is that they were expecting to be second, but now they are first because the competitor (roxadustat) got a CRL or something? Actually, they mention "We had been planning to be seconds of three and that was the rationale for the Vifor deal. Now we're planning to be first of two." So the market opportunity is larger because they are now first to market. That is a change in competitive landscape, not necessarily an operating surprise in terms of their own product performance. But it is a favorable surprise about the market opportunity. However, the question asks: "does management indicate that some REAL, OPERATING part of the business performed AHEAD of management's OWN prior expectations, plan, or timeline in the period just reported" - that is about the company's own operations, not about the competitive landscape. The market opportunity being larger is not about their own operating performance; it's about the market structure. Also, they haven't launched vadadustat yet, so there is no operating performance for that product.
NO Already spoken for downstream: customers are buying to fulfill business they have already secured
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management conveys that customers are buying from the company to serve business those customers have already secured on their own side. The company sells Auryxia (for hyperphosphatemia in dialysis patients) and is preparing to launch vadadustat (for anemia due to CKD). The transcript discusses the market opportunity, launch preparations, and Auryxia revenue growth. Management mentions that the dialysis market has ~560,000 patients, 90% treated with ESAs. They talk about the Vifor distribution relationship with Fresenius and other dialysis providers. They mention TDAPA reimbursement. They discuss Auryxia revenue growth despite COVID challenges. However, do they describe that the customers (dialysis providers) have already secured business on their own side? They talk about the number of dialysis patients and that they are being treated. But is that a commitment? The dialysis providers have existing patients and are treating them. That could be considered as customers having already secured their own business (i.e., they have patients to treat). But management does not explicitly say that the dialysis providers have contracts or commitments that drive their purchases. They talk about the market opportunity and the potential for vadadustat. They mention that Auryxia revenue is growing. But they don't describe that the customers' own order books or commitments are driving purchases. They mention that the market is challenging due to COVID mortality. They don't say that customers have already won projects or have funds earmarked. The closest might be that dialysis providers have patients and are treating them, but that's just the existing market. The question asks if management conveys that the demand behind what the company sells is already committed on the far side of its customers. For Auryxia, the customers are dialysis providers who treat patients with hyperphosphatemia. Those patients are already there. But is that a "commitment"? It's more like an ongoing need. The transcript doesn't describe any specific contracts or awards. For vadadustat, it's not yet approved, so no sales. They talk about launch preparation. They mention TDAPA which is a reimbursement mechanism, but that's not a customer commitment. They mention the Vifor deal giving access to Fresenius, but that's a distribution agreement, not a customer commitment.
NO Outside commitment landed before the results show it: a counterparty has put real weight on the company while reported n
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Need determine if management describes outside counterparty recently made concrete committed decision to put real weight on company, and results not yet reflect. Need only transcript. Let's parse. Company Akebia, vadadustat under FDA review PDUFA March. Partner Otsuka launched in Japan, submitted MAA to EMA. Vifor distribution relationship facilitates access to Fresenius and other dialysis providers, treat up to 60% US dialysis patients. TDAPA reimbursement anticipated six months from regulatory approval. Milestones from Otsuka on approval, Vifor $25M upon US approval and inclusion in TDAPA. Auryxia revenue growth. Question asks: Does management describe that an outside counterparty has RECENTLY made a concrete, committed decision to put real weight on this company (e.g., awarding business, standardizing/designating product, signing major agreement, placing large order, committing resources), AND transcript clear reported results do NOT yet meaningfully reflect that commitment — contribution still ahead/beginning/ramping? Need identify if any outside counterparty decision "recently made" and committed. The transcript mentions existing agreements: Vifor distribution relationship already in place, Otsuka collaboration, MAA submitted. But are these "recently made" decisions? The Vifor deal was previously made, not recent? It says "our distribution relationship with Vifor Pharma will be critical. The agreement facilitates access to Fresenius Medical Care and certain other dialysis providers..." This is an existing agreement, not recently made on this call. Also TDAPA is not a decision by outside party yet; anticipated after approval. Otsuka MAA submission is a committed action by partner, but not necessarily "put real weight" on company? It is a regulatory submission, not awarding business. Milestones contingent on approval. Japan launch by MTPC? "product was launched by our partner MTPC just over a year ago in Japan." That is past, already reflected? Not in US results. Question specifically: "has RECENTLY made a concrete, committed decision to put real weight on this company" Could be Otsuka submitted MAA to EMA last month. That is a concrete committed decision by partner to advance vadadustat in Europe. But does it put real weight? It's a regulatory submission, not revenue. Also results not reflect.
NO Acted like it's already bigger: a recent, in-motion company decision that only makes sense if the step-up is real
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript for specific recent decision enlarging capacity etc, and explained by real demand already present. Let's parse. Company Akebia, vadadustat pending FDA PDUFA March. They are preparing for launch. Did they describe a specific recent decision already acting on that enlarges? They mention "We are investing in pre-commercialization activities" and "Our team has also made significant progress preparing for successful launch, including our medical teams’ efforts to educate physicians, payers and dialysis organizations." But is there a concrete decision? They mention "We have prioritized our spend with expenses to build our supply chain and to invest in value creation initiatives, including work on our 3 times a week studies for vadadustat and continue to have Phase 3 research." That is spending. But is it recent and enlarging? They have supply chain built. They mention "we are working to ensure appropriate commercial drug supply at the time of launch subject to approval." But no specific decision like hiring, capacity. They say "Our commercial team is on the ready to support a second product" and "we have an experienced team" - no new hires. They mention "we are deep in commercial preparedness activities" but no concrete recent decision. Also demand: They cite market opportunity $2B, dialysis patients, but not actual orders. They mention Auryxia revenue growth but that's existing product. For vadadustat, no approval yet, so no real demand. The question asks "does management describe at least one SPECIFIC DECISION THE COMPANY ITSELF RECENTLY MADE AND IS ALREADY ACTING ON ... that visibly ENLARGES what the company is set up to do ... AND does management explain that decision by pointing to DEMAND OR BUSINESS THAT IS ALREADY REAL ... rather than hoped-for demand?" Here, no. They are preparing for launch contingent on approval. They mention "we are investing in pre-commercialization activities" but not specific. They mention "we have prioritized our spend with expenses to build our supply chain" but that's not a specific recent decision? It is ongoing. Also demand is future, not real. So answer NO. Need ensure no other decision: "UT Health has decided to expand their study beyond initial 400 patients" - that's investigator-sponsored study, not company's own decision? It is a decision by UT Health, not Akebia.
NO Analysts still asking about the old story while management keeps pointing to a new driver already producing
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Need determine if clear mismatch between analysts' questions and management pointing to newer driver already producing real results. Let's parse. Company Akebia. Main product Auryxia (current commercial product) for phosphate binder, revenue. Vadadustat investigational HIF-PHI under FDA review, not approved yet. Analysts ask about vadadustat data, commercial prep, supply, TDAPA, Auryxia growth, SG&A, Part D, Europe. Management talks about vadadustat potential, launch prep, data, market opportunity. But vadadustat is not approved, no current revenue. Auryxia is current revenue. Is there mismatch? Analysts focus on vadadustat (newer driver) and Auryxia. Management redirects to vadadustat? Need identify "newer driver already producing real results today" — maybe Auryxia? Management says Auryxia revenue continues to grow, current commercial product, foundation. Analysts ask about Auryxia too. But question asks: analysts keep asking about older established concern (weak/declining legacy business, past losses, macro worry, core business) while management repeatedly redirects to different identifiable part of business that says already producing real results today. Hmm. Let's read transcript carefully. Analyst questions: 1 Alli Bratzel: coming off ASN, feedback from nephrology community on vadadustat profile, comparisons to vadadustat data? (Actually "vadadustat data set presented this weekend" maybe daprodustat? They ask about vadadustat profile and comparisons among "kids" maybe HIFs). Management answers about vadadustat data, daprodustat, confidence. 2 Alethia Young: competitor said panel; update; dapa non-dialysis; Vifor collaboration lock share. Management answers. 3 Eric Joseph: commercial activities, sales/MSL teams support vadadustat, Otsuka; non-dialysis sizing. Management answers. 4 Serge Belanger: commercial prep, product supply, TDAPA; Auryxia growth, generics settlement, outlook. Management answers. 5 Avatar Jones: SG&A expenses next 12 months; Medicare Part D reimbursement of Auryxia. Management answers. 6 Ed Arce: sales footprint size, training; "overall anemia market much larger than expected" comment. Management answers. 7 Bert Hazlett: Europe application timing, reimbursement, issues. Management answers. Analysts are largely asking about vadadustat (new drug, not approved) and Auryxia.
NO Bigger keys handed over: the work customers now entrust has outgrown the work the company historically received
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer only YES or NO based on transcript. Need determine if management describes company now being entrusted with materially larger or more central class of work than historically, step-up visible in actual business being won/performed today. We need parse transcript. Company Akebia, vadadustat pending approval. They discuss potential launch, market opportunity, pre-commercialization. Are they saying they are now being entrusted with larger work? Hmm. They have Auryxia commercial product. Vadadustat not approved yet. They talk about "tremendous opportunity to bring potential first-in-class product to market" "if approved" "preparing for launch" "PDUFA date approaching." They mention "We have a tremendous opportunity" "potential" "if vadadustat is approved." They are not yet winning business? They have collaboration with Otsuka, Vifor distribution. But is that "now being entrusted with materially larger class of work"? The question asks "ON THIS CALL, does management describe that the company is NOW BEING ENTRUSTED WITH A MATERIALLY LARGER OR MORE CENTRAL CLASS OF WORK THAN IT HISTORICALLY RECEIVED — that is, does management convey that the engagements, projects, orders, mandates, or roles it is winning or performing have stepped up in scale or consequence relative to what this company used to be given — and that this step-up is already visible in actual business being won or performed today?" Need answer YES only if management's own words convey one coherent phenomenon as present-tense reality: new business company getting has outgrown historical norm. The transcript is mostly about potential launch, not actual current business. They have Auryxia revenue growth. They have collaboration revenue lower. They have "Vifor Pharma distribution agreement facilitates access to Fresenius... up to 60% US dialysis patients." But that's an agreement, not necessarily "being entrusted" with work? It is a role. But is it "now being entrusted" with larger class? They say "Our cross-functional team with support from Otsuka has developed a robust launch plan. We are investing in pre-commercialization activities..." This is future/contingent on approval. They say "if vadadustat is approved." They are not yet selling vadadustat. The question specifically says "already visible in actual business being won or performed today" not projected/hoped/pipeline.
NO Mid-period crossings: the quarter's story is things that started during it and are still completing
Original model output from the research archive. It may be verbose or include the model's working notes.
The question asks whether management's account of the reported period is built around real business activity that crossed from not-happening to happening partway through the period, and whether management makes clear that this newly started activity is still completing its climb, so the period's reported numbers averaged the 'before' and 'after' and therefore sit below the level at which the business is already running. Let me analyze the transcript carefully. The company is Akebia Therapeutics, developing vadadustat for anemia due to CKD. The PDUFA date is March 29, 2022 (about five months away from the call date of November 9, 2021). The product is NOT yet approved. Key points from the call: - Vadadustat is not yet approved - it's under FDA review - The PDUFA target action date is in March (about 5 months away) - They are preparing for launch but the launch hasn't happened yet - Auryxia is their current commercial product, which has been on the market The question asks about "real business activity that crossed from not-happening to happening partway through the period." Let me look for any such activity. The call discusses: 1. Vadadustat - still under FDA review, not approved, launch is ahead 2. Auryxia - existing product, continuing to grow revenue 3. European MAA submission - was submitted last month (October 2021), which is around the edge of the period 4. UT Health study expansion - investigator-sponsored study The European MAA submission is a regulatory filing, not a revenue-generating business activity. It's a submission, not a launch. The UT Health study expansion - this is a clinical trial expansion, not a commercial activity. Auryxia revenue growth - this is an established product performing well, not a new start. Vadadustat launch - this is still ahead, not yet happened. The PDUFA date is March 2022, about 5 months after the call. So there's no real business activity that "crossed from not-happening to happening" during the period. The main product (vadadustat) is still pending approval. The launch hasn't occurred. The European MAA submission is a regulatory milestone, not a business activity generating revenue. It's a filing, not a start of commercial activity. The UT Health study expansion is a clinical trial, not a commercial activity. Auryxia is an established product - its growth is the normal rhythm of an existing product.
NO Insulated through the downturn: acknowledged industry weakness, but the company's own results are protected by commitmen
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management both acknowledges a weak environment and explains that their own results are shielded by existing protections. The transcript discusses the dialysis market, Auryxia, and vadadustat. There is mention of challenges: "It is worth noting explicitly here that our collaboration revenue is directly tied to work performed on the vadadustat program. Collaboration revenue is reduced because vadadustat related expenses have tapered." That's about collaboration revenue, not market weakness. For Auryxia: "The overall phosphate binder market is down and really significantly due to the disproportionate mortality in this space and so that's been really difficult. And then certainly access to healthcare providers continues to be a challenge." That is an acknowledgment of a weak market environment. Now, does management explain that their own results are shielded by existing protections? They mention that Auryxia net product revenue increased 7% despite the market. But is that due to protections? They say "The growth is reflective of a higher net revenue per pill than previously realized over the last three years and include some one-time true-ups that reflects what we believe is our current payer mix." That is not a structural protection; it's pricing and one-time items. They also mention the settlement with generics that pushes out entry, but that's about future competition, not current shielding from market weakness. They also mention the Vifor collaboration for vadadustat, but that's for a product not yet approved. The question is about the company's own results being shielded from the weakness. The weakness is in the phosphate binder market. Auryxia is a phosphate binder. They acknowledge the market is down, but their revenue grew due to pricing and one-time items, not due to contracts or commitments. They don't describe any take-or-pay, long-term contracts, or committed demand that shields them. They mention "we believe we can continue to grow Auryxia net revenue moving forward" but that's confidence, not a structural shield. Thus, the first half is present: they acknowledge the market is weak. The second half is not: they don't describe existing protections that keep business flowing. They mention the settlement that pushes out generics, but that's about future competition, not current shielding from market weakness.
NO Named counterparty roster suddenly upgraded in caliber
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer only YES or NO. Need evaluate based on transcript. Question asks: Does management describe that caliber of counterparties now doing real business with company has recently stepped up — customers/partners/institutions of size/stature/sophistication not previously transacted with are NOW actually buying/deploying/contracting/committing — and management presents this upgraded roster as recent change grounded in current transactions, with business still early relative to relationships? Need answer YES if all three present. Let's parse transcript. Company Akebia, has Auryxia commercial product, vadadustat pending approval. Management discusses partnerships: Otsuka (partner for Japan/Europe), Vifor Pharma distribution relationship for Fresenius Medical Care and certain other dialysis providers, together treat up to 60% US dialysis patients. Also DaVita and other providers. They are preparing for launch of vadadustat if approved. But vadadustat not approved yet. So no current business from vadadustat. Auryxia is current commercial product. They mention Auryxia revenue growth. Are there new counterparties? The Vifor relationship was previously established? They say "our distribution relationship with Vifor Pharma will be critical. The agreement facilitates access to Fresenius Medical Care and certain other dialysis providers..." This is for future launch, not current transactions. Also Otsuka partnership for Europe MAA submitted. But these are collaborations, not necessarily "real business" with customers? The question asks "counterparties now doing real business with company" — customers, partners, institutions of size. Management describes partnerships with Otsuka and Vifor. But are these recently stepped up? Otsuka is partner for vadadustat, existing collaboration. Vifor agreement was previously announced? They mention "distribution relationship with Vifor Pharma" as critical for launch. But vadadustat not approved, so no current business. Also they mention "Our leadership position in kidney space established with Auryxia" and "experienced team knows payers, healthcare providers, patients." No mention of new high-caliber counterparties actually buying now. They discuss Auryxia net product revenue increased 7%, but no specific new customers. They mention "distribution relationship with Vifor Pharma will be critical" for future.
NO Reordering the pecking order: management describes the company winning on a stage where it used to be too small to play
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? That is, a change in tier, already real, early. Let's examine the transcript. The company is Akebia, with product vadadustat for anemia due to CKD. They are preparing for launch. They have a PDUFA date. They talk about being first to market. They mention that they were expecting to be second or third, but now they are first. For example, John Butler says: "We are excited about vadadustat's potential to be the first-in-class HIF-PHIs in the US. This is a much larger market opportunity than we anticipated just a few months ago." And later: "We had been planning to be seconds of three and that was the rationale for the Vifor deal. Now we're planning to be first of two and that rationale doesn't change." Also: "The $2 billion market opportunity is still the size of the market opportunity. But a few months ago, we were expecting to be the second product to the market, and the opportunity to be the first product to the market and have that opportunity to introduce the first-in-class HIF-PHI is an opportunity we're unexpected -- I haven't been expecting for the last 8 years. We've been expecting to be second. That's how we've been planning. First to market with, we think at least a year or so of a head start over a second entrant, is a really great opportunity for us and a much larger opportunity than we had been considering." So they are now first to market, which is a higher tier than being second. But is that "competing and winning at a level of the market that used to be above it"? They are not yet approved, so they haven't actually won business. They are preparing for launch. The question asks: "ALREADY REAL — the promotion is evidenced by things that have actually happened in the recent period: business won, customers signed, work performed, admission granted, or evaluations prevailed in — not by a pipeline, an ambition, or a marketing claim of leadership." Here, they have not yet launched, so no business won. They are still awaiting approval. They talk about being first to market, but that is a future prospect. They also mention that they have a distribution relationship with Vifor, which gives access to Fresenius, but that was already in place.
NO The open question just closed: management treats a doubt that used to hang over the business as now answered, and names
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management acknowledges a specific doubt or open question that has now been resolved in their favor, with concrete evidence. Looking at the transcript: John Butler discusses the market opportunity, data, and launch preparations. He mentions that they were previously expecting to be second to market, but now they are first. He says: "We have a tremendous opportunity to bring a potential first-in-class product to market... We are excited about vadadustat's potential to be the first-in-class HIF-PHIs in the US. This is a much larger market opportunity than we anticipated just a few months ago." Later, in response to an analyst question, he says: "But a few months ago, we were expecting to be the second product to the market, and the opportunity to be the first product to the market and have that opportunity to introduce the first-in-class HIF-PHI is an opportunity we're unexpected -- I haven't been expecting for the last 8 years. We've been expecting to be second. That's how we've been planning. First to market with, we think at least a year or so of a head start over a second entrant, is a really great opportunity for us and a much larger opportunity than we had been considering." This indicates that previously there was a doubt about whether they would be first or second, but now it's resolved in their favor because the competitor (roxadustat) is not approved? Actually, they mention that they are now first because the other product (roxadustat) had issues? They say "the concerns that were kind of felt around the roxadustat data are starting to -- people are seeing that there's differences between the products and there's a path forward." And they mention daprodustat data confirming safety. So the doubt was about whether they would be first to market, and now they are confident they will be first. But is that a "doubt" that was open? They say they were expecting to be second, but now they are first. That is a shift. They also mention that the FDA has not indicated a panel, which they were prepared for. But the key is: did they acknowledge a specific doubt that is now resolved? They say "This is a much larger market opportunity than we anticipated just a few months ago." That is about market size, not a doubt about the business. They also talk about data supporting approval. But they are still awaiting approval.
NO Management describes competitors unable to respond to what the company is now doing
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: does management explain why competition cannot quickly match what the company is currently winning with, and does it ground both the winning and the inability in present-tense facts? Need to check all three conditions. Condition 1: CURRENT WINNING, REAL AND RECURRING: company is presently taking business, customers, orders, or share — actual wins in the recent period described with substance. In the transcript, management talks about Auryxia revenue growth, but that's for Auryxia, not vadadustat. For vadadustat, it's not approved yet. They talk about launch preparation, but no actual wins. They mention Japan launch by partner MTPC, but that's not US. They talk about "we are excited about vadadustat's potential" and "we believe" etc. No actual current wins for vadadustat. They mention "we have a tremendous opportunity" but not actual wins. So condition 1 fails. Condition 2: NAMED STRUCTURAL REASON RIVALS CANNOT FOLLOW SOON. They mention being first to market, and Vifor distribution relationship giving access to Fresenius and other providers up to 60% of US dialysis patients. That is a structural reason? They say "the agreement facilitates access to Fresenius Medical Care and certain other dialysis providers, which together treat up to 60% of US dialysis patients." That is a specific structural advantage. But is it about competitors not being able to match? They don't explicitly say competitors cannot quickly match. They say "we believe rapid adoption is also likely in the US due to a reimbursement model unique to the dialysis market referred to as TDAPA." That's about reimbursement, not a barrier to competitors. They also mention "being first to market" but that's not a structural barrier; it's just being first. They don't explain what competitors would need to do to match. They mention "we are the only HIF PHI that’s in front of the FDA" but that's about regulatory status, not a structural barrier that prevents competitors from catching up. They don't describe a barrier like years of qualification, capacity, etc. So condition 2 fails. Condition 3: RUNWAY ACKNOWLEDGED: management conveys that the protected winning continues from here. They talk about potential launch and future opportunity, but since they haven't won anything yet, it's not about continuing wins.
Showing the latest 18 of 227 archived research questions.
These archived questions are separate from the newer 500-check scan above.
AKBA call history
Open a quarter only when you want its detailed evidence.
B+ Q1 2025 · Strong call · 2025-05-08Management held guidance steady against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.
B+ Q4 2024 · Strong call · 2025-03-13Management raised guidance against accelerating demand and contracting margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.
View the 20 core call-quality checks
C Q3 2024 · Caution · 2024-11-07Management held guidance steady against accelerating demand and contracting margins. The delivery was unusually candid, rich in specifics, promotional in tone.
View the 20 core call-quality checks
C+ Q2 2024 · Mixed call · 2024-08-10Management held guidance steady against accelerating demand. The delivery was rich in specifics, relaxed under questioning, promotional in tone.
View the 20 core call-quality checks
C Q1 2024 · Caution · 2024-05-09Management held guidance steady against steady demand. The delivery was unusually candid, rich in specifics.
View the 20 core call-quality checks
C Q3 2023 · Caution · 2023-11-08Management held guidance steady against steady demand and expanding margins. The delivery was rich in specifics.
View the 20 core call-quality checks
B+ Q2 2023 · Strong call · 2023-08-25Management held guidance steady against mixed demand signals. The delivery was unusually candid, rich in specifics.
View the 20 core call-quality checks
View 20 earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 2023-05-08 | D | maintained | slowing | stable | 8/9 | 2/9 |
| Q4 2022 | 2023-03-09 | D | maintained | stable | expanding | 6/9 | 4/9 |
| Q3 2022 | 2022-11-03 | D | maintained | slowing | contracting | 7/9 | 3/9 |
| Q2 2022 | 2022-08-06 | D | raised | stable | expanding | 6/9 | 4/9 |
| Q1 2022 | 2022-05-09 | F | maintained | stable | unclear | 7/9 | 3/9 |
| Q3 2021 | 2021-11-09 | C+ | none | stable | unclear | 7/9 | 2/9 |
| Q2 2021 | 2021-08-05 | D | none | stable | unclear | 6/9 | 4/9 |
| Q1 2021 | 2021-05-10 | F | none | stable | contracting | 6/9 | 4/9 |
| Q4 2020 | 2021-02-25 | F | maintained | slowing | contracting | 6/9 | 3/9 |
| Q3 2020 | 2020-11-06 | C | none | mixed | contracting | 7/9 | 2/9 |
| Q1 2020 | 2020-05-05 | B+ | maintained | unclear | unclear | 7/9 | 3/9 |
| Q4 2019 | 2020-03-10 | C | none | unclear | contracting | 6/9 | 3/9 |
| Q3 2019 | 2019-11-12 | F | none | stable | contracting | 6/9 | 4/9 |
| Q2 2019 | 2019-08-10 | C+ | none | accelerating | stable | 7/9 | 2/9 |
| Q1 2019 | 2019-05-09 | C | maintained | accelerating | contracting | 7/9 | 3/9 |
| Q4 2018 | 2019-03-18 | C | none | mixed | contracting | 7/9 | 3/9 |
| Q2 2018 | 2018-08-08 | C | maintained | stable | contracting | 6/9 | 4/9 |
| Q4 2017 | 2018-03-12 | B | none | unclear | contracting | 7/9 | 2/9 |
| Q4 2016 | 2017-03-06 | B | none | unclear | contracting | 7/9 | 2/9 |
| Q4 2015 | 2016-03-14 | A | maintained | unclear | contracting | 7/9 | 1/9 |